Tenet Healthcare Corp.Find Ratings Reports
TENET HEALTHCARE CORP's gross profit margin for the first quarter of its fiscal year 2018 has significantly increased when compared to the same period a year ago. Even though sales decreased, the net income has increased. TENET HEALTHCARE CORP has weak liquidity. Currently, the Quick Ratio is 0.77 which shows a lack of ability to cover short-term cash needs. The company's liquidity has decreased from the same period last year, indicating deteriorating cash flow.
At the same time, stockholders' equity ("net worth") has significantly decreased by 115.11% from the same quarter last year. Overall, the key liquidity measurements indicate that the company is in a position in which financial difficulties could develop in the future.
STOCKS TO BUY: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. To learn more visit www.TheStreetRatings.com.
|Income Statement||Q1 FY18||Q1 FY17|
|Net Sales ($mil)||4699.0||4813.0|
|Net Income ($mil)||99.0||-53.0|
|Balance Sheet||Q1 FY18||Q1 FY17|
|Cash & Equiv. ($mil)||974.0||572.0|
|Total Assets ($mil)||23184.0||24510.0|
|Total Debt ($mil)||14889.0||15218.0|
|Profitability||Q1 FY18||Q1 FY17|
|Gross Profit Margin||13.6||10.01|
|Return on Assets||-2.38||-0.75|
|Return on Equity||0.0||-42.79|
|Debt||Q1 FY18||Q1 FY17|
|Share Data||Q1 FY18||Q1 FY17|
|Shares outstanding (mil)||100.97||100.42|
|Div / share||0.0||0.0|
|Book value / share||-0.64||4.28|
|Institutional Own %||n/a||n/a|
|Avg Daily Volume||2488195.0||2692430.0|
HOLD. This stock’s P/E ratio is negative, making its value useless in the assessment of premium or discount valuation, only displaying that the company has negative earnings per share. Along with this, the price-to-book ratio is also meaningless due to a negative book value for the company, making any comparisons useless. The price-to-sales ratio is well below both the S&P 500 average and the industry average, indicating a discount.
|THC NM||Peers 17.45||THC 2.92||Peers 13.41|
Neutral. The absence of a valid P/E ratio happens when a stock can not be valued on the basis of a negative stream of earnings.
THC's P/E is negative making this valuation measure meaningless.
Discount. The P/CF ratio, a stock’s price divided by the company's cash flow from operations, is useful for comparing companies with different capital requirements or financing structures.
THC is trading at a significant discount to its peers.
|THC 16.45||Peers 15.16||THC NA||Peers 0.94|
Premium. A higher price-to-projected earnings ratio than its peers can signify a more expensive stock or higher future growth expectations.
THC is trading at a significant premium to its peers.
Neutral. The PEG ratio is the stock’s P/E divided by the consensus estimate of long-term earnings growth. Faster growth can justify higher price multiples.
Ratio not available.
|THC NM||Peers 3.27||THC -200.00||Peers 60.33|
Neutral. A lower price-to-book ratio makes a stock more attractive to investors seeking stocks with lower market values per dollar of equity on the balance sheet.
THC's P/B is negative making this valuation measure meaningless.
Lower. Elevated earnings growth rates can lead to capital appreciation and justify higher price-to-earnings ratios.
However, THC is expected to significantly trail its peers on the basis of its earnings growth rate.
|THC 0.17||Peers 0.91||THC -1.68||Peers 6.30|
Discount. In the absence of P/E and P/B multiples, the price-to-sales ratio can display the value investors are placing on each dollar of sales.
THC is trading at a significant discount to its industry on this measurement.
Lower. A sales growth rate that trails the industry implies that a company is losing market share.
THC significantly trails its peers on the basis of sales growth